5 results
DEFA14A
EX-2.1
PBLA
Panbela Therapeutics, Inc.
22 Feb 22
Additional proxy soliciting materials
8:04am
8-K
EX-2.1
PBLA
Panbela Therapeutics, Inc.
22 Feb 22
Acquired lead asset will begin a fully-funded registration trial anticipated to start by year-end
8:03am
10-Q
2016 Q2
EX-2.1
PBLA
Panbela Therapeutics, Inc.
Quarterly report
11 Aug 16
12:00am
8-K
EX-2.1
PBLA
Panbela Therapeutics, Inc.
5 Aug 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
PBLA
Panbela Therapeutics, Inc.
18 Jun 15
Entry into a Material Definitive Agreement
12:00am
- Prev
- 1
- Next